# Iopamidol

Source: https://onco.cc/drugs/iopamidol/  
OnCo record `iopamidol` (Imaging agent). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A CT and X-ray dye made by Bracco, sold for injection into a vein and, in a separate form, into the spinal fluid for myelography.

## Summary

Drugs@FDA lists Bracco's iopamidol products under NDA 018735, first approved 31 December 1985, including Isovue-300 and Isovue-370 for injection and Isovue-M 200 and 300. The Isovue-M label is for myelography, CT myelography and CT cisternography. ATC V08AB04.

## Fields

- Kind: Imaging agent
- Status: approved
- Last checked: 2026-11-04
- Also known as: iopamidol; Isovue; Isovue-M
- Tags: contrast-agents-gaps-2026-11; diagnostic
- Brand: Isovue
- Modality: Iodinated contrast agent for CT, angiography and myelography (intravenous, intrathecal)
- Mechanism: A non-ionic low-osmolar iodinated molecule that makes vessels, organs and enhancing tissue appear bright on X-ray and CT.
- Approvals: US 1985: Radiographic contrast for injection (Isovue) and myelography (Isovue-M)

## Sources

- Drugs@FDA Isovue (NDA 018735): https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018735
- DailyMed label: Isovue-M: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11e893d2-0183-4581-b908-c8b7302c7edb
- WHO ATC index V08AB: low osmolar X-ray contrast media: https://atcddd.fhi.no/atc_ddd_index/?code=V08AB&showdescription=no

## Connected records

- technologies: [CT (computed tomography)](https://onco.cc/technologies/ct/), [Iodinated and barium contrast for CT and X-ray](https://onco.cc/technologies/iodinated-contrast-media/)
- companies: [Bracco (Bracco Imaging and Bracco Diagnostics)](https://onco.cc/companies/bracco/)

---
JSON: https://onco.cc/api/v1/entities/iopamidol.json